Update on pediatric acute respiratory distress syndrome

Related Experiment Video

Updated: Sep 26, 2026

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome (ARDS)
06:22

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome (ARDS)

Published on: April 7, 2021

Michael R Anderson1

  • 1Division of Pediatric Pharmacology and Critical Care, Rainbow Babies and Children's Hospital, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106, USA. mxa35@po.cwru.edu.

Respiratory Care
|April 2, 2003
PubMed

Insights

Pediatric acute respiratory distress syndrome (ARDS) is a severe lung condition in children requiring intensive care. This review covers ARDS definitions, treatments, and prognosis for better clinical management.

Area of Science:

  • Critical Care Medicine
  • Pediatric Pulmonology
  • Respiratory Physiology

Background:

  • Pediatric acute respiratory distress syndrome (ARDS) presents a significant clinical challenge in intensive care settings.
  • ARDS is characterized by severe hypoxemia and respiratory failure, stemming from direct lung injury or systemic inflammation.
  • Effective management necessitates a multidisciplinary intensive care team approach.

Purpose of the Study:

  • To review the evolving definition of pediatric ARDS.
  • To discuss current and emerging intensive care treatment modalities for pediatric ARDS.
  • To examine the prognosis and potential future interventions for pediatric ARDS.

Main Methods:

  • Literature review of pediatric ARDS definitions and treatment strategies.
  • Analysis of intensive care unit (ICU) management protocols.
  • Examination of prognostic factors and outcomes in pediatric ARDS patients.

Main Results:

  • The definition of ARDS has evolved, impacting diagnosis and research.
  • Lung-protective mechanical ventilation strategies and adjunct therapies are key treatment components.
  • Prognosis varies, with ongoing research into novel therapeutic targets.

Conclusions:

  • Pediatric ARDS requires a comprehensive, multidisciplinary ICU approach.
  • Lung-protective ventilation and adjunct therapies are crucial for managing pediatric ARDS.
  • Further research is needed to improve outcomes for this critical pediatric illness.

Related Concept Videos

Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...